Skip to content

Clinical trials

Terminated Phase 1/2 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Terminated Country / region: South Korea Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20123
20133
20144
20158
20164
20179
20185
20194
20208
20218
20228
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated72

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
Pfizer4
Novartis Pharmaceuticals3
Sanofi3
Affimed GmbH2
Amgen2
Bayer2
Bristol-Myers Squibb2
GlaxoSmithKline2
Rainier Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung11
Multiple Myeloma7
Recurrence7
Breast Neoplasms6
Colorectal Neoplasms6
Carcinoma, Hepatocellular5
Stomach Neoplasms5
Neoplasm Metastasis4
Carcinoma, Transitional Cell3
Leukemia, Myeloid, Acute3

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.